Zinc inhibits tumor metastasis by regulating plasminogen activation

International Journal of Cancer Research

Volumn 2, Issue 4, 2006, Pages 376-382

  Tu, Zhigang ^a   Liang, Jun F ^a  

^a Stevens Institute of Technology   (United States)

Author keywords

Cancer therarpy; Metastasis; Plasminogen activator; Zinc

Indexed keywords

PLASMIN; PLASMINOGEN; PLASMINOGEN ACTIVATOR; ZINC CHLORIDE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL MOTION; CELL STRUCTURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOWN REGULATION; FIBRINOLYSIS; HUMAN; HUMAN CELL; METASTASIS INHIBITION; PLASMINOGEN ACTIVATION;

EID: 34248378770     PISSN: 18119727     EISSN: 18119735     Source Type: Journal    
DOI: 10.3923/ijcr.2006.376.382     Document Type: Article

References (16)

1. Baker, EA and D.J. Leaper, 2003. The plasminogen activator and matrix metalloproteinases systems in colorectal cancer: Relationship to tumor pathology. Eur. J. Cancer, 39: 981-988.
2. Costello, L.C. and R.B. Franklin, 2006. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: Connecting the dots, Mol. Cancer, 5: 17.
3. Gonzalez-Gronow, M., H.E. Grenettb, G. Gawdi and S.V. Pizzo, 2005. Angiostatin directly inhibits human prostate tumor cell invasion by blocking plasminogen binding to its cellular receptor. CD26. Exp. Cell Res., 303: 22-31.
4. Huang, L., C. Krischke and Y. Zhang, 2001. Decreased intracellular zinc in human tumorigenic; prostate epithelial cells: A possible role in prostate cancer progression. Cancer Cell Intl., 6: 10.
5. Indyk, J.A., Z.L. Cheri, S.E. Tsirka and S. Strickland 2003. Laminin chain expression suggests that laminin-10 is a major isoform in the mouse hippocampus and is degraded by the tissue plasminogen activator/ plasmin protease cascade during excitotoxic injury. Neurosci, 116: 359-371.
6. Jaiswal, A.S. and S. Narayan, 2004. Zinc stabilizes adenomatous polyposis coli (APC) protein levels and Induces Cell Cycle Arrest in Colon Cancer Cells. J. Cell Biochem., 93: 345-357.
7. Kim, Y., J.H. Park, S.W. Hong and J. Kok 1999. Nonproteolytic neuroprotection by human recombinant tissue plasminogen activator. Science, 284: 647-650.
8. Liang, J.Y., Y.Y. Liu, J. Zou, R.B. Franklin, L.C. Costello and P. Feng, 1999. Inhibitory effect of zinc on human prostatic carcinoma cell growth. Prostate, 40: 200-207.
9. Liang, U., Y.T. Li and V.C. Yang, 2000. The potential mechanism for the effect of heparin on tissue plasminogen activator-Mediated plasminogen activation. Throm. Res., 97: 349-358.
10. WAF1 and inhibits proliferation of colorectal cancer cells. Br. J. Pharm., 137: 597-607.
11. Prasad, A.S., B. Bao, F.W. Beck and F.H. Sarkar, 2001. Zinc activates NF-kappaB in HUT-78 cells. J. Lab Clin. Med., 138: 250-256.
12. Seeds, N.W., M.E. Basham and S.P. Haffke, 1999. Neuronal migration is retarded in mice lacking the tissue plasminogen activator gene. Proc Natl Acad Sci. USA., 96: 14118-14123.
13. Shankar, A.H. and A.S. Prasad, 1998. Zinc and immune fimction: The biological basis of altered resistance to infection. Am. J. Clin. Nutr., 447S-463S.
14. Tsirka, S.E., 2002. Tissue plasminogen activator as a modulator of neuronal survival and function. Biochem. Soc. Trans. 30: 222-225.
15. Uzzo, R.G., P. Leavis, W. Hatch, V.L. Gabai, N. Dulin, N. Zvartau and V.M. Kolenko, 2002. Zinc inhibits nuclear factor-kB activation and sensitizes prostate cancer cells to cytotoxic agents. Clin. Cancer Res., 8: 3679-3583.
16. Zowczak, M., M. Iskra, L. Torlinski and S. Cofta, 2001. Analysis of serum copper and zinc concentrations in cancer patients. Biol. Trace Element Res., 82: 1-8.